Test Code 10129
New York approved

Glycine Encephalopathy Panel

11 genes

2 - 3 weeks (6 - 12 days STAT)

Who is this test for?
  • Individuals with relevant features who have a clinical or suspected diagnosis of glycine encephalopathy (also called nonketotic hyperglycinemia)
  • Individuals with elevated glycine in plasma and CSF with abnormal CSF-to-plasma glycine ratio
  • Individuals with neonatal or early infantile onset of symptoms
Method
NGS with CNV (Exome or Genome Platform)
Specimen(s)

Exome Platform: Blood, DNA, Buccal, Saliva, Tissue

Genome Platform: Blood, DNA

Order Options

OTHER OPTIONS
for standard institutional pricing.

Explore related tests

Questions? We can help.

Getting support has never been easier. Let us connect you with our specialists that will assist you with anything from understanding products to navigating insurance questions.